secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2025-01-16T23:59:59+00:00
Accession:  0001493152-25-002477
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim Q4 preliminary: $15.2M revenue (+13% YoY), net loss $20-24M (vs $3M Q3), cash $5M
--------------------------------------------------------------------------------

- Revenue ~$15.2M, up 13% YoY from $13.4M and up sequentially from $15.0M in Q3.
- GAAP net loss expected $20-24M, compared to $3M in Q3, driven by $12M R&D for new product launches.
- Also: $4M COGS adjustment, $2M credit loss provision, $1M restructuring charge.
- Cash expected ~$5M at year-end; launched new 5G hotspots and smartphones with Verizon, Telstra, Bell Canada.
- Expanded global distribution to Europe, Africa, Australia; new manufacturing in Taiwan (TAA certified) and Vietnam.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315225002477/0001493152-25-002477-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315225002477/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-002477

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer